R56 DK078244/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	7
2009	6
2010	10
2011	7
2012	12
2013	3
2014	9
2015	3
2016	6
2017	3
2018	4
2019	4
2020	5
2021	5
2022	3
2023	5
2024	7

1

IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Rajasekaran A, Julian BA, Rizk DV. Rajasekaran A, et al. Am J Med Sci. 2021 Feb;361(2):176-194. doi: 10.1016/j.amjms.2020.10.003. Epub 2020 Oct 8. Am J Med Sci. 2021. PMID: 33309134 Free PMC article. Review.

2

Glycosylation in health and disease.

Reily C, Stewart TJ, Renfrow MB, Novak J. Reily C, et al. Nat Rev Nephrol. 2019 Jun;15(6):346-366. doi: 10.1038/s41581-019-0129-4. Nat Rev Nephrol. 2019. PMID: 30858582 Free PMC article. Review.

3

IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Hastings MC, Rizk DV, Kiryluk K, Nelson R, Zahr RS, Novak J, Wyatt RJ. Hastings MC, et al. Pediatr Nephrol. 2022 Apr;37(4):719-733. doi: 10.1007/s00467-021-04950-y. Epub 2021 Apr 5. Pediatr Nephrol. 2022. PMID: 33818625 Free PMC article. Review.

4

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Rizk DV, Maillard N, Julian BA, Knoppova B, Green TJ, Novak J, Wyatt RJ. Rizk DV, et al. Front Immunol. 2019 Mar 19;10:504. doi: 10.3389/fimmu.2019.00504. eCollection 2019. Front Immunol. 2019. PMID: 30941137 Free PMC article. Review.

5

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.

Rajasekaran A, Green TJ, Renfrow MB, Julian BA, Novak J, Rizk DV. Rajasekaran A, et al. Drugs. 2023 Nov;83(16):1475-1499. doi: 10.1007/s40265-023-01940-2. Epub 2023 Sep 25. Drugs. 2023. PMID: 37747686 Free PMC article. Review.

6

Secondary IgA nephropathy.

Saha MK, Julian BA, Novak J, Rizk DV. Saha MK, et al. Kidney Int. 2018 Oct;94(4):674-681. doi: 10.1016/j.kint.2018.02.030. Epub 2018 May 24. Kidney Int. 2018. PMID: 29804660 Free PMC article. Review.

7

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.

Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y. Makita Y, et al. Kidney Int. 2020 Feb;97(2):340-349. doi: 10.1016/j.kint.2019.08.022. Epub 2019 Sep 5. Kidney Int. 2020. PMID: 31748116 Free PMC article.

8

IgA nephropathy enigma.

Mestecky J, Novak J, Moldoveanu Z, Raska M. Mestecky J, et al. Clin Immunol. 2016 Nov;172:72-77. doi: 10.1016/j.clim.2016.07.011. Epub 2016 Jul 18. Clin Immunol. 2016. PMID: 27444044 Free PMC article. Review.

9

O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

Novak J, King RG, Yother J, Renfrow MB, Green TJ. Novak J, et al. Glycobiology. 2024 Sep 30;34(11):cwae060. doi: 10.1093/glycob/cwae060. Glycobiology. 2024. PMID: 39095059 Review.

10

GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy.

Jemelkova J, Stuchlova Horynova M, Kosztyu P, Zachova K, Zadrazil J, Galuszkova D, Takahashi K, Novak J, Raska M. Jemelkova J, et al. Kidney Int Rep. 2023 Feb 13;8(5):1068-1075. doi: 10.1016/j.ekir.2023.02.1072. eCollection 2023 May. Kidney Int Rep. 2023. PMID: 37180502 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year